For FY18, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics were up +4.1% YoY. Acelity remains the global market leader followed by S&N and Mölnlycke. Advanced Dressings, the workhorse of Advanced Wound Care, accounts for 52.3% of WW revenues, up +3.3% YoY. Skin/Dermal Substitute (CTP) revenue was up +10.7% YoY, lower than previous years, but still double-digit gains. WW NPWT was up +4.3% YoY, with traditional devices having a slight uptick and single-use driving the increase of +28.9%.
- Wound Biologics – CTPs Continue to Drive Increase
- Mixed Results for Market Leaders
- NPWT – Single-use Devices Continue to Shine
- Advanced Dressings – ConvaTec Impacts Market Negatively End of Year'
- FY18, Q418 US Skin Substitute (CTPs) Revenue and Market Shares
- FY18/Q418 Growth in Constant and Reported for Key Companies
- Other Happenings for the Quarter
Smith & Nephew (S&N) announced it has agreed to acquire Osiris for $660MM, allowing a greater presence in the fast-growing regenerative medicine market and providing a boost to its wound management business. Organogenesis Holdings announced the completion of the merger between Organogenesis and Avista Healthcare Public Acquisition Corp. Organogenesis is now a wholly owned subsidiary of AHPAC. Mölnlycke acquired M&J Airlaid, a Danish manufacturer of nonwoven materials, to secure future supply of a key component in their Mepilex Border dressings.